You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
An adjunct to prolonged exposure therapy for treating refractory PTSD patients
SBC: MICROTRANSPONDER, INC. Topic: 101DESCRIPTION provided by applicant The Specific Aim of this proposal is to test the feasibility of using vagus nerve stimulation VNS as an adjunct to prolonged exposure therapy PE for treating PTSD patients who are refractory to PE PE is the treatment of choice for such patients However PE is successful in as few as of cases Refractory PTSD patients have high rates of suicide substa ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
An eHealth solution for posttraumatic stress and pain screening integrated in pediatric injury care
SBC: Radiant Creative Group, LLC Topic: NICHDDESCRIPTION provided by applicant Each year million US children are injured affecting the child his her family and society which often bears the cost Among school age children age to injuries lead to million emergency department ED visits and hospital admissions annually resulting in $ billion in medical costs and $ billion more in work loss costs Approxima ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Next Generation, Low Cost Tracking System for Healthcare
SBC: Q-Track Corporation Topic: 600DESCRIPTION provided by applicant The goal of the Phase I study is to determine the feasibility of piloting a low cost Real Time Location System RTLS for use in healthcare based on a novel technology known as Near Field Electromagnetic The proposed QHealth system promises to support a number of healthcare applications such as equipment management workflow optimization hand hygiene complian ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
An Innovative Device Integrating Cryopreservation, Storage, and Artificial Insemination of Mouse Sperm
SBC: PARATECHS CORP Topic: 100DESCRIPTION provided by applicant ParaTechs Corporation aims to provide researchers with advanced technology and methods to simplify procedures for laboratory animal models While actively supporting efforts to `reduce replace and refineandapos animal use ParaTechs provides safe and efficient alternatives for surgical procedures We have already brought to market a nonsurgical embryo transfe ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Non Toxic solution to develop next generation of insecticidal bed nets
SBC: LYNNTECH INC. Topic: NIAIDPROJECT SUMMARY Insect borne disease is a world wide problem of enormous scale and devastating impact particularly in less developed countries Despite the development of new insecticides current techniques of using a single insecticide over long periods of time for mosquito control result in acquired resistance posing a significant risk of loss of effectiveness of insecticides This proposal de ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A novel inhaled c-kit/PDGFR inhibitor for the treatment of asthma
SBC: Pulmokine, Inc. Topic: NHLBIDESCRIPTION provided by applicant The purpose of this project is to develop an inhaled combined c kit PDGFR inhibitor as a treatment for asthma Asthma is a chronic inflammatory disease characterized by airway hyper responsiveness and remodeling A key underlying mechanism of asthma involves activation of T helper type Th lymphocytes with production of allergen specific IgE and activati ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction
SBC: ENDOPROTECH, INC. Topic: NHLBIDESCRIPTION provided by applicant According to the CDC in ischemic heart disease is the leading cause of death worldwide and in the US approximately patients died of ischemic heart disease It is well established in clinical practice that recanalization of he infarct related artery IRA using percutaneous coronary intervention PCI enhances myocardial salvage and outcomes in pa ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Novel Recombinant Protein as an Effective Therapy for Acute Kidney Injury
SBC: THERASOURCE, LLC Topic: 400PROJECT DESCRIPTION The primary objective of this project is to demonstrate the feasibility of developing recombinant human milk fat globule epidermal growth factor factor rhMFG E as a novel and effective therapeutic for patients with acute kidney injury AKI associated with ischemia due to low renal perfusion AKI is a major cause of prolonged hospitalization and increased mortality Ische ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Novel TLR Agonist Based Adjuvant for Poliovirus Vaccine
SBC: BUFFALO BIOLABS, LLC Topic: NIAIDPROJECT SUMMARY ABSTRACT Antiviral vaccines remain the largest segment of the rapidly growing global vaccine market Despite near complete eradication of poliovirus through vaccination efforts continued need for inactivated polio vaccine IPV is projected to reach million doses per year worldwide Among major obstacles to widespread use of the current IPV formulation are its high cost and in ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Novel Treatment of Vasomotor Symptoms in Prostate Cancer Patients
SBC: AGYPHARMA, LLC Topic: NCIDESCRIPTION provided by applicant Because prostate cancer is an androgen dependent malignancy in the early stages androgen depletion therapy ADT has been shown to be effective in improving survival when administered timely in the course of the disease On the other hand the benefits may be offset by severe neurological symptoms primarily hot flushes Since ADT depletes the substrate necessa ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health